However, the liver-enriched receptor FGFR4 is also thought to mediate the tumorigenic effects of FGF19, since inactivation of FGFR4 via gene knockout or a neutralizing antibody reduces the tumour burden in FGF19 transgenic mice15. Here, FGFR4 is linked to neoplasm.